2Seventy Historical Balance Sheet

TSVT Stock

USD 2.62 0.13 5.22%

Trend analysis of 2Seventy Bio balance sheet accounts such as Total Current Liabilities of 66.8 M, Total Stockholder Equity of 229.7 M, Other Liabilities of 6.3 M or Net Tangible Assets of 194.1 M provides information on 2Seventy Bio's total assets, liabilities, and equity, which is the actual value of 2Seventy Bio to its prevalent stockholders. By breaking down trends over time using 2Seventy Bio balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining 2Seventy Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether 2Seventy Bio is a good buy for the upcoming year.

2Seventy Bio Inventory

11.66 Million

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in 2Seventy Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For more information on how to buy 2Seventy Stock please use our How to Invest in 2Seventy Bio guide.

About 2Seventy Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of 2Seventy Bio at a specified time, usually calculated after every quarter, six months, or one year. 2Seventy Bio Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of 2Seventy Bio and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which 2Seventy currently owns. An asset can also be divided into two categories, current and non-current.

2Seventy Bio Balance Sheet Chart

At this time, 2Seventy Bio's Other Current Assets are comparatively stable compared to the past year. Other Stockholder Equity is likely to gain to about 925.8 M in 2025, whereas Short and Long Term Debt Total is likely to drop slightly above 235.5 M in 2025.

Common Stock Shares Outstanding Total Assets Short Long Term Debt Total Other Current Liab

Add Fundamental

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Total Assets

Total assets refers to the total amount of 2Seventy Bio assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in 2Seventy Bio books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Most accounts from 2Seventy Bio's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into 2Seventy Bio current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in 2Seventy Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For more information on how to buy 2Seventy Stock please use our How to Invest in 2Seventy Bio guide.At this time, 2Seventy Bio's Other Current Assets are comparatively stable compared to the past year. Other Stockholder Equity is likely to gain to about 925.8 M in 2025, whereas Short and Long Term Debt Total is likely to drop slightly above 235.5 M in 2025.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	270.2M	256.7M	295.2M	235.5M
Total Assets	656.7M	565.4M	650.2M	574.1M

Short Long Term Debt Total Total Assets

2Seventy Bio balance sheet Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Good Will	Non Current Liabilities Total	Capital Lease Obligations	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital
Common Stock Shares Outstanding		0.64	0.77	-0.78	-0.88	0.67	-0.85	0.76	0.68	0.64	-0.71	-0.68	0.7	0.39	0.81	0.83	0.68	0.6	-0.69	0.7	0.77	-0.52	-0.69	0.84	0.53	0.67
Total Assets	0.64		0.98	-0.39	-0.65	1.0	-0.86	0.98	0.95	0.27	-0.97	-0.86	0.98	0.93	0.96	0.52	0.99	0.94	-0.78	1.0	0.98	-0.97	-0.84	0.87	0.97	1.0
Short Long Term Debt Total	0.77	0.98		-0.49	-0.74	0.99	-0.92	0.99	0.94	0.38	-0.97	-0.86	0.98	0.86	0.99	0.64	0.99	0.92	-0.81	0.99	1.0	-0.93	-0.87	0.92	0.93	0.99
Other Current Liab	-0.78	-0.39	-0.49		0.93	-0.45	0.6	-0.52	-0.48	-0.46	0.54	0.74	-0.49	-0.19	-0.47	-0.65	-0.42	-0.43	0.59	-0.43	-0.49	0.32	0.38	-0.65	-0.2	-0.45
Total Current Liabilities	-0.88	-0.65	-0.74	0.93		-0.7	0.84	-0.75	-0.72	-0.52	0.76	0.87	-0.73	-0.43	-0.72	-0.81	-0.67	-0.69	0.79	-0.69	-0.74	0.56	0.67	-0.87	-0.49	-0.7
Total Stockholder Equity	0.67	1.0	0.99	-0.45	-0.7		-0.87	0.99	0.93	0.25	-0.97	-0.89	0.98	0.9	0.96	0.54	1.0	0.95	-0.77	0.99	0.99	-0.96	-0.86	0.87	0.94	1.0
Other Liab	-0.85	-0.86	-0.92	0.6	0.84	-0.87		-0.89	-0.86	-0.56	0.89	0.81	-0.92	-0.66	-0.93	-0.87	-0.87	-0.86	0.89	-0.88	-0.92	0.76	0.92	-0.99	-0.78	-0.87
Net Tangible Assets	0.76	0.98	0.99	-0.52	-0.75	0.99	-0.89		0.92	0.31	-0.96	-0.9	0.97	0.85	0.98	0.58	0.99	0.92	-0.76	0.98	0.99	-0.94	-0.84	0.89	0.91	0.99
Property Plant And Equipment Net	0.68	0.95	0.94	-0.48	-0.72	0.93	-0.86	0.92		0.42	-0.96	-0.84	0.95	0.9	0.91	0.61	0.92	0.89	-0.9	0.96	0.94	-0.9	-0.79	0.9	0.94	0.93
Current Deferred Revenue	0.64	0.27	0.38	-0.46	-0.52	0.25	-0.56	0.31	0.42		-0.43	-0.19	0.39	0.2	0.43	0.7	0.27	0.11	-0.67	0.35	0.38	-0.22	-0.24	0.63	0.31	0.25
Net Debt	-0.71	-0.97	-0.97	0.54	0.76	-0.97	0.89	-0.96	-0.96	-0.43		0.9	-0.99	-0.9	-0.94	-0.59	-0.96	-0.89	0.87	-0.98	-0.97	0.95	0.77	-0.93	-0.92	-0.97
Accounts Payable	-0.68	-0.86	-0.86	0.74	0.87	-0.89	0.81	-0.9	-0.84	-0.19	0.9		-0.88	-0.73	-0.81	-0.55	-0.87	-0.89	0.75	-0.85	-0.86	0.83	0.73	-0.83	-0.71	-0.89
Cash	0.7	0.98	0.98	-0.49	-0.73	0.98	-0.92	0.97	0.95	0.39	-0.99	-0.88		0.89	0.96	0.62	0.98	0.92	-0.85	0.99	0.98	-0.96	-0.84	0.93	0.94	0.98
Non Current Assets Total	0.39	0.93	0.86	-0.19	-0.43	0.9	-0.66	0.85	0.9	0.2	-0.9	-0.73	0.89		0.82	0.26	0.9	0.8	-0.71	0.92	0.86	-0.97	-0.62	0.71	0.97	0.9
Non Currrent Assets Other	0.81	0.96	0.99	-0.47	-0.72	0.96	-0.93	0.98	0.91	0.43	-0.94	-0.81	0.96	0.82		0.66	0.97	0.88	-0.79	0.98	0.99	-0.9	-0.87	0.92	0.92	0.96
Other Assets	0.83	0.52	0.64	-0.65	-0.81	0.54	-0.87	0.58	0.61	0.7	-0.59	-0.55	0.62	0.26	0.66		0.53	0.58	-0.8	0.56	0.64	-0.37	-0.76	0.85	0.44	0.54
Cash And Short Term Investments	0.68	0.99	0.99	-0.42	-0.67	1.0	-0.87	0.99	0.92	0.27	-0.96	-0.87	0.98	0.9	0.97	0.53		0.93	-0.75	0.99	0.99	-0.97	-0.85	0.87	0.94	1.0
Net Receivables	0.6	0.94	0.92	-0.43	-0.69	0.95	-0.86	0.92	0.89	0.11	-0.89	-0.89	0.92	0.8	0.88	0.58	0.93		-0.74	0.92	0.92	-0.87	-0.92	0.84	0.85	0.95
Good Will	-0.69	-0.78	-0.81	0.59	0.79	-0.77	0.89	-0.76	-0.9	-0.67	0.87	0.75	-0.85	-0.71	-0.79	-0.8	-0.75	-0.74		-0.81	-0.81	0.72	0.71	-0.94	-0.77	-0.77
Non Current Liabilities Total	0.7	1.0	0.99	-0.43	-0.69	0.99	-0.88	0.98	0.96	0.35	-0.98	-0.85	0.99	0.92	0.98	0.56	0.99	0.92	-0.81		0.99	-0.96	-0.83	0.89	0.96	0.99
Capital Lease Obligations	0.77	0.98	1.0	-0.49	-0.74	0.99	-0.92	0.99	0.94	0.38	-0.97	-0.86	0.98	0.86	0.99	0.64	0.99	0.92	-0.81	0.99		-0.93	-0.87	0.92	0.93	0.99
Inventory	-0.52	-0.97	-0.93	0.32	0.56	-0.96	0.76	-0.94	-0.9	-0.22	0.95	0.83	-0.96	-0.97	-0.9	-0.37	-0.97	-0.87	0.72	-0.96	-0.93		0.72	-0.79	-0.96	-0.96
Other Current Assets	-0.69	-0.84	-0.87	0.38	0.67	-0.86	0.92	-0.84	-0.79	-0.24	0.77	0.73	-0.84	-0.62	-0.87	-0.76	-0.85	-0.92	0.71	-0.83	-0.87	0.72		-0.85	-0.76	-0.86
Other Stockholder Equity	0.84	0.87	0.92	-0.65	-0.87	0.87	-0.99	0.89	0.9	0.63	-0.93	-0.83	0.93	0.71	0.92	0.85	0.87	0.84	-0.94	0.89	0.92	-0.79	-0.85		0.8	0.87
Total Liab	0.53	0.97	0.93	-0.2	-0.49	0.94	-0.78	0.91	0.94	0.31	-0.92	-0.71	0.94	0.97	0.92	0.44	0.94	0.85	-0.77	0.96	0.93	-0.96	-0.76	0.8		0.94
Net Invested Capital	0.67	1.0	0.99	-0.45	-0.7	1.0	-0.87	0.99	0.93	0.25	-0.97	-0.89	0.98	0.9	0.96	0.54	1.0	0.95	-0.77	0.99	0.99	-0.96	-0.86	0.87	0.94

Click cells to compare fundamentals

2Seventy Bio Account Relationship Matchups

2Seventy Bio balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	312.6M	759.7M	656.7M	565.4M	650.2M	574.1M
Short Long Term Debt Total	127.6M	282.2M	270.2M	256.7M	295.2M	235.5M
Other Current Liab	28.0M	67.8M	58.4M	25.7M	23.1M	38.9M
Total Current Liabilities	75.9M	98.4M	79.8M	59.8M	53.8M	66.8M
Total Stockholder Equity	74.6M	359.8M	310.5M	255.3M	293.6M	229.7M
Property Plant And Equipment Net	260.5M	310.4M	296.6M	278.1M	319.8M	308.7M
Current Deferred Revenue	820K	5M	3M	15.4M	17.7M	18.6M
Net Debt	255.2M	151.8M	199.1M	181.7M	163.5M	168.8M
Accounts Payable	7.2M	6.0M	7.2M	6.0M	5.4M	7.5M
Cash	(127.6M)	130.4M	71.0M	75.0M	86.2M	90.5M
Non Current Assets Total	287.5M	468.1M	355.8M	327.7M	376.8M	381.3M
Non Currrent Assets Other	8.3M	38.6M	38.4M	38.1M	43.9M	30.2M
Cash And Short Term Investments	(127.6M)	362.2M	266.3M	217.0M	249.5M	128.5M
Net Receivables	10.7M	17.0M	21.0M	13.4M	15.4M	15.3M
Liabilities And Stockholders Equity	312.6M	759.7M	656.7M	565.4M	650.2M	574.1M
Non Current Liabilities Total	162.1M	301.5M	266.4M	250.3M	287.9M	252.6M
Capital Lease Obligations	127.6M	282.2M	270.2M	256.7M	295.2M	235.5M
Other Current Assets	14.4M	9.5M	13.7K	7.4M	6.6M	7.2M
Other Stockholder Equity	(74.6M)	400.0M	607.0M	766.7M	881.7M	925.8M
Total Liab	238.0M	399.9M	346.2M	310.1M	356.6M	344.4M
Net Invested Capital	74.6M	359.8M	310.5M	255.3M	293.6M	229.7M
Property Plant And Equipment Gross	290.5M	350.5M	344.5M	335.0M	385.3M	351.7M
Total Current Assets	25.1M	291.6M	300.9M	237.8M	273.4M	192.8M
Accumulated Other Comprehensive Income	74.6M	(712K)	(2.9M)	(204K)	(183.6K)	(174.4K)
Non Current Liabilities Other	24.1M	3.3M	259.0M	2.4M	2.8M	2.6M
Net Working Capital	(50.8M)	193.2M	221.1M	178.0M	204.7M	214.9M
Short Term Debt	30.6M	19.5M	11.2M	26.4M	30.4M	21.8M
Intangible Assets	5.6M	9.9M	7.3M	6.6M	5.9M	6.2M
Common Stock	74.6M	2K	4K	5K	4.5K	4.3K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for 2Seventy Stock Analysis

When running 2Seventy Bio's price analysis, check to measure 2Seventy Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 2Seventy Bio is operating at the current time. Most of 2Seventy Bio's value examination focuses on studying past and present price action to predict the probability of 2Seventy Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 2Seventy Bio's price. Additionally, you may evaluate how the addition of 2Seventy Bio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

2Seventy Historical Balance Sheet

2Seventy Bio Inventory

11.66 Million

About 2Seventy Balance Sheet Analysis

2Seventy Bio Balance Sheet Chart

Common Stock Shares Outstanding

Total Assets

2Seventy Bio balance sheet Correlations

2Seventy Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

2Seventy Bio balance sheet Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for 2Seventy Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Non Current Liabilities Total	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Capital Lease Obligations	+ 1.0	Short Long Term Debt Total
Cash And Short Term Investments	+ 1.0	Total Stockholder Equity
Net Invested Capital	+ 1.0	Total Stockholder Equity

Cash	- 0.99	Net Debt
Other Stockholder Equity	- 0.99	Other Liab
Non Current Liabilities Total	- 0.98	Net Debt
Inventory	- 0.97	Cash And Short Term Investments
Inventory	- 0.97	Non Current Assets Total
Net Invested Capital	- 0.97	Net Debt